The effect of ranitidine (as effervescent tablets) on the quality of life of gord patients

British Journal of Clinical Practice

Volumn 50, Issue 4, 1996, Pages 190-196

  Stagey, J H ^a,b   Miocevich, M L ^a   Sacks, G E ^a  

^a GLAXOSMITHKLINE   (United Kingdom)

^b Disease Management Executive   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

HISTAMINE H2 RECEPTOR ANTAGONIST; RANITIDINE;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; GASTROESOPHAGEAL REFLUX; GENERAL PRACTICE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SYMPTOM; UNITED KINGDOM;

ADOLESCENT; ADULT; ANTI-ULCER AGENTS; CASE-CONTROL STUDIES; FEMALE; GASTROESOPHAGEAL REFLUX; HUMANS; MALE; MIDDLE AGED; QUALITY OF LIFE; RANITIDINE;

EID: 0030011070     PISSN: 00070947     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (8)

1. Management guidelines for gastro-oesophageal reflux disease summary. London: Synergy Medical Education, 1992.
2. Spilker B, Frank R et al. Quality of life bibliography and indexes. Medical Care 1990; 28 (12): xx.
3. Jaeschke R, Singer J, Guyatt G. Measurement of health status. Ascertaining the minimal clinically important difference. Controlled Clinical Trials 1989; 10:407-415.
4. Juniper E, Guyatt G et al. Determining a minimal important change in a disease specific quality of life questionnaire. J Clin Epidemiol 1994; 4(1): 81-87.
5. Ware J. SF-36 health survey manual & interpretation guide. Boston: Nimrod Press, 1993.
6. Jenkinson C, Coulter A, Wright L. Shortform (SF36) health survey questionnaire: normative data for adults of working age. Br MedJ 1993; 306: 1437-1440.
7. Chal K, Stacey J, Sacks G. The effect of ranitidine (Zantac) on symptom relief and quality of life of patients with gastro-oesophageal reflux disease (GORD). Br J Gen Pract, in print.
8. Taha AS, Morran C et al. The health assessment questionnaire as a predictor of nonsteroidal peptic ulcération. Br J Rheumatol 1993; 32: 135-138.